Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Return on Equity (2016 - 2025)

Marimed (MRMD) has disclosed Return on Equity for 14 consecutive years, with 0.32% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Equity fell 11.0% to 0.32% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.32%, a 11.0% decrease, with the full-year FY2024 number at 0.19%, up 6.0% from a year prior.
  • Return on Equity was 0.32% for Q3 2025 at Marimed, down from 0.28% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 1.01% in Q2 2021 to a low of 0.32% in Q3 2025.
  • A 5-year average of 0.09% and a median of 0.04% in 2022 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: crashed -8449bps in 2021, then grew 4bps in 2022.
  • Marimed's Return on Equity stood at 0.21% in 2021, then increased by 17bps to 0.25% in 2022, then plummeted by -186bps to 0.21% in 2023, then rose by 10bps to 0.19% in 2024, then tumbled by -67bps to 0.32% in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Return on Equity are 0.32% (Q3 2025), 0.28% (Q2 2025), and 0.28% (Q1 2025).